AVXL: Anavex Life Sciences Corp Financial Statements
Balance sheet, income statement, and cash flow statements for Anavex Life Sciences Corp (AVXL).
$481.64M Market Cap.
AVXL Market Cap. (MRY)
AVXL Shares Outstanding (MRY)
AVXL Assets (MRY)
Total Assets
$135.57M
Total Liabilities
$15.30M
Total Investments
$0
AVXL Income (MRY)
Revenue
$0
Net Income
-$43.00M
Operating Expense
$52.88M
AVXL Cash Flow (MRY)
CF Operations
-$30.81M
CF Investing
$0
CF Financing
$11.97M
AVXL Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total Assets | $135,567,000 (-12.19%) | $154,386,000 (1.10%) | $152,705,000 (-5.51%) | $161,616,490 (367.88%) |
Assets Current | $135,567,000 (-12.19%) | $154,386,000 (1.10%) | $152,705,000 (-5.51%) | $161,616,490 (367.88%) |
Assets Non-Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Goodwill & Intangible Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Shareholders Equity | $120,263,000 (-15.22%) | $141,852,000 (-0.45%) | $142,491,000 (-5.52%) | $150,818,104 (453.73%) |
Property Plant & Equipment Net | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Cash & Equivalents | $132,187,000 (-12.47%) | $151,024,000 (1.25%) | $149,158,000 (-1.94%) | $152,107,745 (420.04%) |
Accumulated Other Comprehensive Income | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Deferred Revenue | $842,000 (-8.18%) | $917,000 (106.53%) | $444,000 (0.04%) | $443,831 (0%) |
Total Investments | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Non-Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Inventory | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Receivables | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Payables | $9,627,000 (122.74%) | $4,322,000 (12.99%) | $3,825,000 (-19.30%) | $4,739,781 (18.82%) |
Accumulated Retained Earnings (Deficit) | -$336,071,000 (-14.67%) | -$293,069,000 (-19.35%) | -$245,564,000 (-24.28%) | -$197,585,864 (-23.74%) |
Tax Assets | $2,449,000 (-9.60%) | $2,709,000 (-15.16%) | $3,193,000 (-65.05%) | $9,136,831 (88.41%) |
Tax Liabilities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Debt | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Debt Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Debt Non-Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Liabilities | $15,304,000 (22.10%) | $12,534,000 (22.71%) | $10,214,000 (-5.41%) | $10,798,386 (47.81%) |
Liabilities Current | $15,304,000 (22.10%) | $12,534,000 (22.71%) | $10,214,000 (-5.41%) | $10,798,386 (47.81%) |
Liabilities Non-Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
AVXL Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Revenues | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Cost of Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Selling General & Administrative Expense | $11,039,000 (-8.31%) | $12,039,000 (-7.89%) | $13,070,000 (44.93%) | $9,018,000 (53.98%) |
Research & Development Expense | $41,838,000 (-4.30%) | $43,717,000 (15.30%) | $37,916,000 (14.95%) | $32,984,000 (30.72%) |
Operating Expenses | $52,877,000 (-5.16%) | $55,756,000 (9.36%) | $50,986,000 (21.39%) | $42,002,000 (35.11%) |
Interest Expense | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Income Tax Expense | $0 (0%) | $7,000 (-98.04%) | $358,000 (33.58%) | $268,000 (1082.49%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | -$43,002,000 (9.48%) | -$47,505,000 (0.99%) | -$47,978,000 (-26.56%) | -$37,909,000 (-44.25%) |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income | -$43,002,000 (9.48%) | -$47,505,000 (0.99%) | -$47,978,000 (-26.56%) | -$37,909,000 (-44.25%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income Common Stock | -$43,002,000 (9.48%) | -$47,505,000 (0.99%) | -$47,978,000 (-26.56%) | -$37,909,000 (-44.25%) |
Weighted Average Shares | $83,468,049 (4.61%) | $79,787,596 (3.74%) | $76,909,993 (10.18%) | $69,802,960 (19.95%) |
Weighted Average Shares Diluted | $83,468,049 (4.61%) | $79,787,596 (3.74%) | $76,909,993 (10.18%) | $69,802,960 (19.95%) |
Earning Before Interest & Taxes (EBIT) | -$43,002,000 (9.47%) | -$47,498,000 (0.26%) | -$47,620,000 (-26.51%) | -$37,641,000 (-43.35%) |
Gross Profit | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Operating Income | -$52,877,000 (5.16%) | -$55,756,000 (-9.36%) | -$50,986,000 (-21.39%) | -$42,002,000 (-35.11%) |
AVXL Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Net Cash Flow from Investing | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Cash Flow from Financing | $11,975,000 (-59.61%) | $29,651,000 (39.29%) | $21,288,000 (-86.11%) | $153,243,000 (440.53%) |
Net Cash Flow from Operations | -$30,812,000 (-10.89%) | -$27,785,000 (-14.63%) | -$24,238,000 (20.23%) | -$30,384,000 (-42.73%) |
Net Cash Flow / Change in Cash & Cash Equivalents | -$18,837,000 (-1109.49%) | $1,866,000 (163.25%) | -$2,950,000 (-102.40%) | $122,859,000 (1639.38%) |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Capital Expenditure | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Issuance (Repayment) of Debt Securities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Issuance (Purchase) of Equity Shares | $11,975,000 (-59.61%) | $29,651,000 (34.81%) | $21,995,000 (-86.15%) | $158,794,000 (452.25%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Share Based Compensation | $9,438,000 (-42.35%) | $16,370,000 (-10.93%) | $18,379,000 (123.29%) | $8,231,000 (68.78%) |
Depreciation Amortization & Accretion | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
AVXL Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Gross Margin | - | - | - | - |
Profit Margin | - | - | - | - |
EBITDA Margin | - | - | - | - |
Return on Average Equity (ROAE) | -33.00% (1.20%) | -33.40% (-3.09%) | -32.40% (8.22%) | -35.30% (65.53%) |
Return on Average Assets (ROAA) | -30.20% (1.63%) | -30.70% (-0.66%) | -30.50% (6.15%) | -32.50% (60.22%) |
Return on Sales (ROS) | - | - | - | - |
Return on Invested Capital (ROIC) | 513.20% (-8.06%) | 558.20% (-55.91%) | 1266.00% (-76.37%) | 5358.50% (319.39%) |
Dividend Yield | 0% (0%) | 0% (0%) | 0% (0%) | 0% (0%) |
Price to Earnings Ratio (P/E) | -10.92 (-0.05%) | -10.92 (34.41%) | -16.64 (49.93%) | -33.24 (-228.76%) |
Price to Sales Ratio (P/S) | - | - | - | - |
Price to Book Ratio (P/B) | 4 (5.84%) | 3.78 (-32.97%) | 5.64 (-37.35%) | 9.01 (-10.38%) |
Debt to Equity Ratio (D/E) | 0.13 (44.32%) | 0.09 (22.22%) | 0.07 (0.00%) | 0.07 (-73.13%) |
Earnings Per Share (EPS) | -0.52 (13.33%) | -0.6 (3.23%) | -0.62 (-14.81%) | -0.54 (-20.00%) |
Sales Per Share (SPS) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Free Cash Flow Per Share (FCFPS) | -0.37 (-6.03%) | -0.35 (-10.48%) | -0.32 (27.59%) | -0.43 (-18.85%) |
Book Value Per Share (BVPS) | 1.44 (-18.95%) | 1.78 (-4.05%) | 1.85 (-14.25%) | 2.16 (361.75%) |
Tangible Assets Book Value Per Share (TABVPS) | 1.62 (-16.07%) | 1.94 (-2.57%) | 1.99 (-14.21%) | 2.31 (289.73%) |
Enterprise Value Over EBIT (EV/EBIT) | -8 (0.00%) | -8 (42.86%) | -14 (56.25%) | -32 (-255.56%) |
Enterprise Value Over EBITDA (EV/EBITDA) | -7.97 (0.85%) | -8.04 (41.19%) | -13.67 (57.16%) | -31.92 (-240.34%) |
Asset Turnover | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Current Ratio | 8.86 (-28.08%) | 12.32 (-17.62%) | 14.95 (-0.11%) | 14.97 (216.56%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | -$30,812,000 (-10.89%) | -$27,785,000 (-14.63%) | -$24,238,000 (20.23%) | -$30,384,000 (-42.73%) |
Enterprise Value (EV) | $342,882,537 (-10.23%) | $381,962,639 (-41.34%) | $651,170,499 (-45.80%) | $1,201,387,462 (387.88%) |
Earnings Before Tax (EBT) | -$43,002,000 (9.47%) | -$47,498,000 (0.26%) | -$47,620,000 (-26.51%) | -$37,641,000 (-43.35%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$43,002,000 (9.47%) | -$47,498,000 (0.26%) | -$47,620,000 (-26.51%) | -$37,641,000 (-43.35%) |
Invested Capital | -$11,924,000 (-30.00%) | -$9,172,000 (-37.57%) | -$6,667,000 (-416.97%) | -$1,289,641 (35.92%) |
Working Capital | $120,263,000 (-15.22%) | $141,852,000 (-0.45%) | $142,491,000 (-5.52%) | $150,818,104 (453.73%) |
Tangible Asset Value | $135,567,000 (-12.19%) | $154,386,000 (1.10%) | $152,705,000 (-5.51%) | $161,616,490 (367.88%) |
Market Capitalization | $481,638,537 (-10.27%) | $536,779,803 (-33.27%) | $804,369,851 (-40.81%) | $1,358,947,507 (396.21%) |
Average Equity | $130,144,250 (-8.49%) | $142,223,932 (-3.87%) | $147,950,087 (37.60%) | $107,518,726 (318.89%) |
Average Assets | $142,422,000 (-8.08%) | $154,938,546 (-1.64%) | $157,524,665 (35.23%) | $116,486,119 (262.27%) |
Invested Capital Average | -$8,379,250 (1.52%) | -$8,508,562 (-126.20%) | -$3,761,479 (-435.48%) | -$702,456 (65.82%) |
Shares | 84,795,517 (3.47%) | 81,951,115 (5.14%) | 77,942,815 (2.95%) | 75,707,382 (25.78%) |
